<DOC>
	<DOCNO>NCT02277938</DOCNO>
	<brief_summary>Several factor discourage implementation cancer screen population general , would result early diagnosis expect improved survival . Concurrent vivo vitro research show drug acetylation activity increase cancer . Amantadine may value detect presence cancer . Accordingly , study examine Amantadine eliminate body cancer patient . This important step validate cancer detection method implement economically screen large number people .</brief_summary>
	<brief_title>Acetylamantadine Excretion Cancer Patients</brief_title>
	<detailed_description>The study involve screen volunteer patient various type cancer provide first indication type cancer stage tumor burden acetylamantadine find patient ' plasma , saliva urine sample . Volunteers provide complete first morning urine collection prior amantadine ingestion . The volunteer ingest therapeutic dose amantadine ( 200 mg : 2x100mg capsule ) , least 2 hour breakfast ( nothing eat drink except water midnight schedule appointment ) , complete urine collect 2 4 hour ( plus minus 1 hour ) amantadine ingestion . In addition , blood sample take venipuncture 2 4 hour drug ingestion . The patient ask provide saliva sample time urine sample take drug ingestion .</detailed_description>
	<mesh_term>Amantadine</mesh_term>
	<criteria>newly diagnose untreated cancer ( GI , lung , prostate breast cancer ) Any previous adverse reaction Amantadine currently pregnant lactate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>